Credentialing for participation in clinical trials

被引：15

作者：

Followill, David S. ^{[1
]}

Urie, Marcia ^{[2
]}

Galvin, James M. ^{[3
,4
]}

Ulin, Kenneth ^{[2
,5
]}

Xiao, Ying ^{[3
,4
]}

FitzGerald, Thomas J. ^{[2
,5
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Radiol Phys Ctr, 8060 El Rio St, Houston, TX 77054 USA

[2] Univ Massachusetts, Med Sch, Dept Radiat Oncol, Qual Assurance Review Ctr, Lincoln, RI USA

[3] Thomas Jefferson Univ, Jefferson Med Coll, Dept Radiat Oncol, Philadelphia, PA 19107 USA

[4] Radiat Therapy Oncol Grp, Philadelphia, PA USA

[5] Univ Massachusetts, Med Sch, Dept Radiat Oncol, Worcester, MA USA

来源：

FRONTIERS IN ONCOLOGY | 2012年 / 2卷

关键词：

credentialing; clinical trials; radiation oncology; quality assurance; clinical cooperative groups;

D O I：

10.3389/fonc.2012.00198

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The National Cancer Institute (NCI) clinical cooperative groups have been instrumental over the past 50 years in developing clinical trials and evidence-based clinical trial processes for improvements in patient care. The cooperative groups are undergoing a transformation process to launch, conduct, and publish clinical trials more rapidly. Institutional participation in clinical trials can be made more efficient and include the expansion of relationships with international partners. This paper reviews the current processes that are in use in radiation therapy trials and the importance of maintaining effective credentialing strategies to assure the quality of the outcomes of clinical trials. The paper offers strategies to streamline and harmonize credentialing tools and processes moving forward as the NCI undergoes transformative change in the conduct of clinical trials.

引用

页数：8

共 50 条

[41] Barriers to participation in cancer prevention clinical trials
Hall, Michael J.
Egleston, Brian
Miller, Suzanne M.
Buzaglo, Joanne S.
Millard, Jennifer
Ridgway, Caroline
Damjanov, Nevena
Sprandio, John D.
Meropol, Neal J.
[J]. ACTA ONCOLOGICA, 2010, 49 (06) : 757 - 766
[42] Attitudes and Perceptions toward Participation in Clinical Trials
Magyarody, N.
Wald, R.
Jiang, D.
Burns, K. E. A.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[43] Decision-making and participation in clinical trials
Mancini, J.
Geneve, J.
Dalenc, F.
Genre, D.
Monnier, A.
Kerbrat, P.
Largillier, R.
Serin, D.
Rios, M.
Roche, H.
Jimenez, M.
Tarpin, C.
Julian-Reynier, C.
[J]. ONCOLOGIE, 2008, 10 (02) : 149 - 154
[44] Patient participation in thoracic cancer clinical trials
Pujol, Jean-Louis
Chakra, Mohammad
Milleron, Bernard
[J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (01) : 3 - 5
[45] Examining Participation Disparities in Cancer Clinical Trials
Moore, Ami R.
Lewis, Taylor Hudson
Abah, Theresa
Celebi, Mehmet
Amey, Foster K.
[J]. ONCOLOGY NURSING FORUM, 2023, 50 (01) : 79 - 89
[46] The 2005 ASCO Clinical Trials Participation Awards
不详
[J]. JOURNAL OF ONCOLOGY PRACTICE, 2005, 1 (04) : 168 - +
[47] Fostering the participation of diverse women in clinical trials
LaRosa, JH
[J]. JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 1999, 8 (05): : 699 - 699
[48] A perspective on African American participation in clinical trials
Shaya, Fadia T.
Gbarayor, Confidence M.
Yang, Huiwen Keri
Agyeman-Duah, Marriette
Saunders, Elijah
[J]. CONTEMPORARY CLINICAL TRIALS, 2007, 28 (02) : 213 - 217
[49] PATIENTS ATTITUDES TO PARTICIPATION IN CLINICAL-TRIALS
BEVAN, EG
CHEE, LC
MCGHEE, SM
MCINNES, GT
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 35 (02) : 204 - 207
[50] Rheumatoid arthritis patients' participation in clinical trials
Rachel Murphy
[J]. Nature Clinical Practice Rheumatology, 2006, 2 (3): : 123 - 123

← 1 2 3 4 5 →